Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892132 · ClinicalTrials.gov registry record · NA
Evaluation of a Supervised Clinical Feeding Intervention
A NA study, sponsored by Boston Children's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT06892132 is a NA study that has not yet begun recruiting, run by Boston Children's Hospital. The registered enrollment target is 320 participants.
The verdict
NCT06892132, a NA study, has not yet begun recruiting, sponsored by Boston Children's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
Peanut allergies affect approximately 2.5% of children; are associated with significant mortality, morbidity, and economic costs; and often lead to persistent peanut allergies in adulthood. We now know however that early introduction of peanut products to infants prior to age 7 months and maintained in the diet regularly significantly reduces the rate of peanut allergies. Unfortunately, recent research shows that even when parents know the recommendations to feed peanut products early and often, \<50% of parents report introducing peanuts by age 9 months, \<45% are offering peanut products several times a week, and \<20% are offering the recommended 2 teaspoons at each feeding. Many parents cite a fear of reactions or a lack of knowledge on how to safely feed peanut products at this age. While there are recommendations to offer the first feeding in clinic this has not been widely implemented in general pediatrics clinics and we have no research to say this is an effective way to increase peanut consumption at home. This research is being conducted to assess the effectiveness of a supervised peanut feeding clinic in a pediatric office to increase rate of guideline recommended peanut consumption in infants by 9 months of age.
Interventions
- OTHER Handout
- OTHER Supervised feeding intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06892132
The ClinicalTrials.gov registry entry for NCT06892132 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Handout is the first listed.
NCT06892132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06892132 about?
NCT06892132 is a clinical study titled "Evaluation of a Supervised Clinical Feeding Intervention". Peanut allergies affect approximately 2.5% of children; are associated with significant mortality, morbidity, and economic costs; and often lead to persistent peanut allergies in adulthood. We now know however that early introduction of peanut products to infants prior to age 7 months and maintained...
What is the current status of trial NCT06892132?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2025-05-01. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT06892132?
The interventions under investigation include: Handout (OTHER), Supervised feeding intervention (OTHER).
Who is sponsoring clinical trial NCT06892132?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.